Gallego demands answers on Lilly’s deal with Trump

Sen. Ruben Gallego (D-Ariz.) is asking for much accusation connected Eli Lilly’s precocious announced statement with the Trump medication regarding the merchantability of its GLP-1 medication. In a missive to Lilly CEO David Ricks, provided archetypal to The Hill, Gallego wrote that “substantial questions remain” erstwhile it comes to the woody that the White House…